Resistance to Targeted Therapies in Breast Cancer -  - Grāmatas - Springer International Publishing AG - 9783319701417 - 2017. gada 13. decembris
Ja vāks un nosaukums nesakrīt, pareizs ir nosaukums

Resistance to Targeted Therapies in Breast Cancer 1st ed. 2017 edition


Saņemt e-pastu, kad prece būs pieejama
Do you have a profile? Pierakstīties
Pievienot savam iMusic vēlmju sarakstam

Not rated yet

We present an in-depth description of resistance to targeted therapies in breast cancer. Targeted therapies discussed here include those used to treat ER+ or Her2+ breast cancers (i.e., Tamoxifen or trastuzumab) or those targeting signaling pathways aberrantly activated in triple negative breast cancer (i.e., EGFR and Wnt signaling).


184 pages, 12 Illustrations, black and white; XV, 184 p. 12 illus.

Mediji Grāmatas     Book
Izlaists 2017. gada 13. decembris
ISBN13 9783319701417
Izdevēji Springer International Publishing AG
Lapas 184
Izmēri 150 × 220 × 20 mm   ·   471 g
Valoda Vācu  
Redaktors Prosperi, Jenifer R.

Vairāk no tā paša izdevēja